Dr. Reddy’s Q3 and 9M FY16 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.51
February 9, 2016 7:22 AM ESTDr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.51, versus $0.51 reported last year. Revenue for the quarter came in at $599 million, versus $581 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
... More


